Log in to save to my catalogue

Systemic, perioperative management of muscle-invasive bladder cancer and future horizons

Systemic, perioperative management of muscle-invasive bladder cancer and future horizons

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6054138

Systemic, perioperative management of muscle-invasive bladder cancer and future horizons

About this item

Full title

Systemic, perioperative management of muscle-invasive bladder cancer and future horizons

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Clinical oncology, 2017-04, Vol.14 (4), p.221-234

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Key Points
High metastatic relapse rates after radical cystectomy indicate muscle-invasive bladder cancer (MIBC) is a systemic disease at diagnosis in many patients
The use of adjuvant chemotherapy to decrease relapse rates after radical cystectomy is not supported by level 1 evidence, and the postoperative morbidity of patients often preclud...

Alternative Titles

Full title

Systemic, perioperative management of muscle-invasive bladder cancer and future horizons

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6054138

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6054138

Other Identifiers

ISSN

1759-4774,1759-4782

E-ISSN

1759-4782

DOI

10.1038/nrclinonc.2016.188

How to access this item